Predictive factors for additional non-sentinel lymph node involvement in breast cancer patients with one positive sentinel node

Tumori. 2015 Jan-Feb;101(1):78-83. doi: 10.5301/tj.5000220. Epub 2015 Jan 24.

Abstract

Aim: The aim of this study was to identify a subgroup of breast cancer patients in whom it is possible to avoid axillary lymph node dissection (ALND) when the sentinel lymph node (SLN) is positive.

Methods: A series of 292 patients treated with breast-conserving surgery or mastectomy underwent ALND after positive SLN detection. To correlate SLN metastasis with the chances of finding additional metastasis in non-SLNs we evaluated the main clinicopathological characteristics. No patients received adjuvant radiotherapy to the axillary region.

Results: Fifty-six patients (35.4%) with positive SLNs for macrometastases (n = 158) had additional metastases upon completion ALND compared with 7 patients (5.2%) with micrometastases in the SLN (n = 132). Cases with a higher number of positive axillary lymph nodes tended to have higher pT stage (p = 0.004). In multivariate analysis, pT was confirmed as an independent predictor of non-SLN metastases (OR = 2.40; 95% CI = 1.16-4.99). No patients with micrometastases in SLN and cancer lt;10 mm had additional positive non-SLNs.

Conclusions: Our results, in agreement with the major published studies, suggest that ALND can be avoided in selected patients without the need for additional treatment to the axillary region.

MeSH terms

  • Adult
  • Aged
  • Axilla
  • Biomarkers, Tumor / analysis
  • Breast Neoplasms / chemistry
  • Breast Neoplasms / pathology*
  • Carcinoma, Ductal, Breast / pathology
  • Carcinoma, Lobular / pathology
  • Female
  • Humans
  • Lymph Node Excision* / adverse effects
  • Lymph Nodes / pathology*
  • Lymph Nodes / surgery
  • Lymphatic Metastasis / diagnosis
  • Mastectomy / methods
  • Middle Aged
  • Neoplasm Grading
  • Neoplasm Micrometastasis / diagnosis
  • Neoplasm Staging
  • Predictive Value of Tests
  • Risk Assessment
  • Risk Factors
  • Sentinel Lymph Node Biopsy*

Substances

  • Biomarkers, Tumor